Results 81 to 90 of about 1,148 (137)

Assessing ethical practices among community pharmacists in Nigeria: prevalence, drivers, challenges, and implications—a mixed methods study

Frontiers in Public Health
IntroductionGiven the accessibility of community pharmacists as the first point of care in Nigeria and their expanding role in optimizing public health, it is critical that they employ evidence-based, ethical practices.
Olanrewaju Olamide Popoola, Olanrewaju Olamide Popoola, Igbagboyemi Adebowale Adebisi, Igbagboyemi Adebowale Adebisi, Adebowale Sylvester Adeyemi, Damilola Samson Adepitan, Damilola Samson Adepitan, Opeyemi Fortunate Oladeru, Opeyemi Fortunate Oladeru   +8 more
doaj   +1 more source

Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries.

PLoS ONE
Malaria and Human Immunodeficiency Virus infections are among the top 10 causes of death in low income countries. Furthermore, many medicines used in these treatment areas are substandard, which contributes to the high death rate.
Amor R Cáceres-Pérez, Javier Suárez-González, Ana Santoveña-Estévez, José B Fariña   +3 more
doaj   +1 more source

Health, Economic, and Social Impacts of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review of Methodological Approaches. [PDF]

Am J Trop Med Hyg, 2023
Salami RK, Valente de Almeida S, Gheorghe A, Njenga S, Silva W, Hauck K.   +5 more
europepmc   +1 more source

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches. [PDF]

Am J Trop Med Hyg, 2022
Ozawa S, Higgins CR, Nwokike JI, Phanouvong S.   +3 more
europepmc   +1 more source

Quality improvement in medicines regulation: a retrospective analysis of the Pharmacy Board of Sierra Leone before and during quality management system implementation

BMC Health Services Research
Background National Medicines Regulatory Authorities like the Pharmacy Board of Sierra Leone are responsible for protecting and promoting public health, implementing regulatory standards, and maintaining a supply chain with an assured supply of medical ...
Michael Lahai, Laurie Lake, Ahmed Vandy, Bondu Sebba, Mohamed Sesay, Onome T. Abiri, Joy Johnson, Tamba Buffa, Abdulai Kanu, Mohamed Bawoh, James P. Komeh, Wiltshire C.N Johnson   +11 more
doaj   +1 more source

The silent epidemic of substandard and falsified medicines in low- and middle-income countries: heed lessons from the tragic deaths of children in Indonesia. [PDF]

Int J Surg, 2023
MohanaSundaram A, Padhi BK, Mohanty A, Shrestha S, Sah R.   +4 more
europepmc   +1 more source

Trade in substandard and falsified medicines

, 2022
Nhomsai Hagen, Cathrin Hauk, Lutz Heide
openaire   +1 more source

Value for money of medicine sampling and quality testing: evidence from Indonesia

BMJ Global Health
Background Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM, however, there is remarkably scarce evidence ...
Elizabeth Pisani, Adrian Gheorghe, Katharina Hauck, Amalia Hasnida, Sara Valente de Almeida, Sarah Njenga, Yunita Nugrahani, Ayu Rahmawati, Rahmi Mawaddati, Stanley Saputra, Yusi Anggriani   +10 more
doaj   +1 more source

Prevalence of Substandard and Falsified Essential Medicines [PDF]

JAMA Network Open, 2018
openaire   +2 more sources

Tackling the Burden of Substandard and Falsified Medicines and Health Technologies in Somaliland and Somalia

SSRN Electronic Journal
Background: The problem posed by the substandard and falsified (SF) medicines is a rising global challenge. WHO estimates that sales of SF medical products in low- and middle-income countries is around US$ 30 billion whereby 1 in 10 medical is substandard or falsified.
Saed Nuh Ahmed, Angela Brand
openaire   +1 more source